The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids
Open accessAbstract
C-reactive protein (CRP) is an acute-phase protein that binds specifically to phosphorylcholine (PC) as a component of microbial capsular polysaccharide and participates in the innate immune response against microorganisms. CRP elevation also is a major risk factor for cardiovascular disease. We previously demonstrated that EO6, an antioxidized LDL autoantibody, was a T15 clono-specific anti-PC antibody and specifically binds to PC on oxidized phosphatidylcholine (PtC) but not on native PtC. Similarly, EO6 binds apoptotic cells but not viable cells. In addition, such oxidized phospholipids are recognized by macrophage scavenger receptors, implying that these innate immune responses participate in the clearance because of their proinflammatory properties. We now report that CRP binds to oxidized LDL (OxLDL) and oxidized PtC (OxPtC), but does not bind to native, nonoxidized LDL nor to nonoxidized PtC, and its binding is mediated through the recognition of a PC moiety. Reciprocally, CRP binds to PC, which can be competed for by OxLDL and OxPtC but not by native LDL, nonoxidized PtC, or by oxidized phospholipids without the PC headgroup. CRP also binds to apoptotic cells, and this binding is competed for by OxLDL, OxPtC, and PC. These data suggest that CRP binds OxLDL and apoptotic cells by recognition of a PC moiety that becomes accessible as a result of oxidation of PtC molecule. We propose that, analogous to EO6 and scavenger receptors, CRP is a part of the innate immune response to oxidized PC-bearing phospholipids within OxLDL and on the plasma membranes of apoptotic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Self-citationDecoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154
Human C-reactive protein: expression, structure, and function
Volanakis, J. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00042-6 · Cited by 926
Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 845
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754
Gershov, D., Kim, S., Brot, N., & Elkon, K. B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1353 · Cited by 695
Shaw, P. X., Hörkkö, S., Chang, M.-K., Curtiss, L. K., Palinski, W., Silverman, G. J., & Witztum, J. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8472 · Cited by 676
Self-citationTorzewski, J., Torzewski, M., Bowyer, D. E., Fröhlich, M., Koenig, W., Waltenberger, J., Fitzsimmons, C., & Hombach, V. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.9.1386 · Cited by 561
Self-citationHörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4533 · Cited by 559
Self-citationPalinski, W., Hörkkö, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., & Witztum, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118853 · Cited by 559
Self-citationChang, M.-K., Bergmark, C., Laurila, A., Hörkkö, S., Han, K.-H., Friedman, P., Dennis, E. A., & Witztum, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6353 · Cited by 459
Self-citationShih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910376199 · Cited by 425
Self-citationThe Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor II
Bharadwaj, D., Stein, M.-P., Volzer, M., Mold, C., & Clos, T. W. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.585 · Cited by 391
Parthasarathy, S., Steinbrecher, U. P., Barnett, J., Witztum, J. L., & Steinberg, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.9.3000 · Cited by 378
Self-citationHörkkö, S., Miller, E., Dudl, E., Reaven, P., Curtiss, L. K., Zvaifler, N. J., Terkeltaub, R., Pierangeli, S. S., Branch, D. W., Palinski, W., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118854 · Cited by 348
Self-citationRegulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326
Bhakdi, S., Torzewski, M., Klouche, M., & Hemmes, M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2348 · Cited by 326
Self-citationHuber, J., Vales, A., Mitulovic, G., Blumer, M., Schmid, R., Witztum, J. L., Binder, B. R., & Leitinger, N. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.101525 · Cited by 296
Self-citationThomas, C. A., Li, Y., Kodama, T., Suzuki, H., Silverstein, S. C., & El Khoury, J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.147 · Cited by 282
Yamada, Y., Doi, T., Hamakubo, T., & Kodama, T. (1998) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050191 · Cited by 268
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers
Volanakis, J. E., & Wirtz, K. W. A. (1979) · Nature · doi:10.1038/281155a0 · Cited by 236
Friedman, P., Hörkkö, S., Steinberg, D., Witztum, J. L., & Dennis, E. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108860200 · Cited by 195
Self-citationBoullier, A., Gillotte, K. L., Hörkkö, S., Green, S. R., Friedman, P., Dennis, E. A., Witztum, J. L., Steinberg, D., & Quehenberger, O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9163 · Cited by 190
Self-citationEvidence for a Role of Phospholipid Oxidation Products in Atherogenesis
Berliner, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00098-6 · Cited by 182
Torzewski, M., Klouche, M., Hock, J., Meßner, M., Dorweiler, B., Torzewski, J., Gabbert, H. E., & Bhakdi, S. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.3.369 · Cited by 182
Self-citationSerum Amyloid P Component and C-Reactive Protein Mediate Phagocytosis Through Murine FcγRs
Mold, C., Gresham, H. D., & Clos, T. W. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1200 · Cited by 173
Oxidized phospholipids and isoprostanes in atherosclerosis
Witztum, J. L., & Berliner, J. A. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00008 · Cited by 170
Self-citationScavenger receptor class B type I as a receptor for oxidized low density lipoprotein
Gillotte-Taylor, K., Boullier, A., Witztum, J. L., Steinberg, D., & Quehenberger, O. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30281-9 · Cited by 165
Self-citationSTUDIES OF ACUTE PHASE PROTEIN
Kushner, I., & Kaplan, M. H. (1961) · The Journal of Experimental Medicine · doi:10.1084/jem.114.6.961 · Cited by 163
NONOXIDATIVE MODIFICATIONS OF LIPOPROTEINS IN ATHEROGENESIS
Tabas, I. A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.123 · Cited by 156
C-reactive protein reacts with the U1 small nuclear ribonucleoprotein.
Clos, T. W. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2553 · Cited by 124
Bioactive phospholipid oxidation products
Marathe, G. K., Harrison, K. A., Murphy, R. C., Prescott, S. M., Zimmerman, G. A., & McIntyre, T. M. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00234-3 · Cited by 117
Oxidized LDL Contains Inflammatory PAF-Like Phospholipids
Marathe, G. K., Prescott, S. M., Zimmerman, G. A., & McIntyre, T. M. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00100-1 · Cited by 110
Analysis of the binding of C-reactive protein to histones and chromatin.
Clos, T. W. D., Zlock, L. T., & Rubin, R. L. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.12.4266 · Cited by 105
Immune recognition of OxLDL in atherosclerosis
Kearney, J. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10426 · Cited by 51
Cited by
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
“CRP binds oxidized LDL and oxidized phospholipids, which then enhances uptake by macrophages (263), promoting the formation of foam”
Metadata
- Authors
- Chang, M.-K., Binder, C. J., Torzewski, M., & Witztum, J. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-09-20
- Volume
- 99
- Issue
- 20
- Pages
- 13043-13048
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2163451548
- Cited by
- 521
- References
- 37
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.